MAPK3 and fragile X syndrome: For this reason, they also assessed levels of ERK1/2 phosphorylation in FXS subjects, which showed a trend towards higher phosphorylation but was not statistically significant, suggesting that ERK signaling is not the primary signaling pathway that is affected in the FXS [121].